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Background: Combination analgesics provide more effective pain relief for a broader spectrum of pain.
This research examines the possible potentiation of the analgesic effect of different classes of antidepressants
when combined with aspirin in thermal model of pain using Albino mice.
Methods: Different groups of six animals each were injected intraperitoneally by different doses of aspirin
(50, 100, or 200 mg/kg), imipramine (2.5, 7.5, 15 or 30 mg/kg), fluoxetine (1.25, 2.5, 5 or 7.5 mg/kg),
mirtazapine (1.25, 2.5, or 5 mg/kg) and a combination of a fixed dose of aspirin (100 mg/kg) with the different
doses of the three antidepressants. One hour later the analgesic effect of these treatments were evaluated
against thermally induced pain. All data were subjected to statistical analysis using unpaired Student’s t-test.
Results: Aspirin had no analgesic effect in thermally induced pain. The three selected antidepressants
produced dose dependent analgesia. The addition of a fixed dose of aspirin to imipramine significantly
increased the reaction time (RT) of the lowest dose (by 23%) and the highest dose (by 20%). The addition
of the fixed dose of aspirin to fluoxetine significantly increased RT by 13% of the dose 2.5 mg/kg. Finally,
the addition of the fixed dose of aspirin significantly potentiated the antinociceptive effect of the different
doses of mirtazapine (RT was increased by 24, 54 and 38% respectively).
Conclusion: Combination of aspirin with an antidepressant might produce better analgesia, increasing the
efficacy of pain management and reduces side effects by using smaller doses of each drug.
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N
onsteroidal anti-inflammatory drugs (NSAIDs)
are nonspecific analgesics and can potentially
be used for any type of acute or chronic pain.
Because they are both analgesic and anti-inflammatory,
the NSAIDs are among the most widely used of all
therapeutic classes of drugs (1). Most antidepressant
medications are analgesics, and can relieve chronic
pain even if the patient has no coexisting depression.
The specific antidepressant effects are also important 
alleviating chronic depression is important in helping
patients deal more effectively with pain (2). Nevertheless,
no single analgesic agent is perfect and no single
analgesic can treat all types of pain. Yet, each agent
has distinct advantages and disadvantages compared to
the others. Hence, clinical outcomes might be improved
under certain conditions with the use of a combination
of analgesics, rather than reliance on a single agent (3).
By activating multiple pain-inhibitory pathways, combi-
nation analgesics can provide more effective pain relief
for a broader spectrum of pain, and might also reduce
adverse drug reactions (3). Many combinations have
been used for the treatment of different types of pain
(4, 5). However, no study of the analgesic effect of
the combined treatment of aspirin with antidepressant
drugs was reported before. Therefore an experimental
study using Albino mice was undertaken to examine
the analgesic effect of the combined treatment with
aspirin and different classes of antidepressant drugs
including tricyclic antidepressants (TCA), selective sero-
tonin uptake inhibitor (SSRI) and noradrenergic &
specific serotonergic antidepressants (NaSSAs). This
was done by studying the antinociceptive effect of these
drugs either given alone or in combination with aspirin
in thermal pain.
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Animals used
Albino mice weighting 2530 g were used. The animals
were bred at the Department of Pharmacology, Faculty
of Pharmacy, Tripoli University. The animals were kept at
room temperature between 20 and 258C with constant
humidity and 12 h light-dark cycle with food and water
ad-lib. All experiments were performed at times between
10.00 and13.00 h to minimize diurnal variations.
Drugs and chemicals
Aspirin ampoules containing 500 mg were obtained from
Sanofi Aventis-France. Imipramine hydrochloride am-
poules containing 10 mg/2 ml were obtained from Polfa
Poland. Fluoxetine hydrochloride and Mirtazapine were
supplied by Sigma  Aldrich dealers in Tripoli. Tween 80
and Acetic acid 1% (v/v) were obtained from Riedel-De
Haen AG Seelzf-Hannover Germany.
Drugs administration
Aspirin and Fluoxetine hydrochloride were dissolved in
0.9% saline. Imipramine hydrochloride solution was
diluted with 0.9% saline. Mirtazapine was suspended in
1% Tween 80 in water. All these drugs were administered
by the intraperitoneal (i.p.) route in a volume of 5 ml/kg
body weight. Different groups of six animals each were
injected intraperitoneally by different doses of aspirin
(50, 100, or 200 mg/kg), imipramine (2.5, 7.5, 15 or
30 mg/kg), fluoxetine (1.25, 2.5, 5 or 7.5 mg/kg),
mirtazapine (1.25, 2.5, or 5 mg/kg) and a combination
of a fixed dose of aspirin (100 mg/kg) with the different
doses of the three antidepressant drugs. One hour later
the analgesic effects of these treatments were evaluated
against thermally (hotplate) induced pain.
Thermally induced pain
Hot-plate Analgesia Meter (model  DS 37 manufactured
by Soael Milan-Italy) was used as a mean of inducing
thermal pain. The plate temperature was held at a set
point by electronic thermostat set at (5590.2) 8C (6, 7).
Mice were brought to the testing room and allowed to
acclimatize for 10 min before the test begins. The mouse
was placed on the hot plate and the latency to respond
with either a hind paw lick, hind paw flick, or jump
(which ever comes first) was measured in seconds. The
mouse was immediately removed from the hot plate and
returned to its home cage. If a mouse did not respond
within 30 sec, the test was terminated and the mouse was
removed from the hot plate (8). Baseline measurement for
each mouse was taken just prior to drug administration
(pretreatment values or self control) and again 60 min
after drug administration. Experiments were performed
according to a protocol approved by our animal care
committee.
Data presentation and statistical analysis
The degree of antinociception for each mouse was
expressed as the percentage increase in reaction time
(RT) in seconds calculated according to the formula
(% increase in RT[T*100/C]), where C is the RT before
treatment and T is the RT after treatment.
Data generated from the above studies were statistically
analyzedwith Excel software. Results for each group were
expressed as Mean9SE. One way analysis of variance
(ANOVA) was used to see the differences in the effects
among the different doses, and unpaired Student’s t-test
(two samples assuming equal variances) to determine
which population means were different. A P value of
B0.05 was considered statistically significant.
Results
Antinociceptive effect of aspirin
Different doses of aspirin (50200 mg/kg) produced no
significant change in the reaction time in the hot plate
test (Table 1).
The antinociceptive effect of imipramine alone
and in combination with aspirin
Different doses of imipramine produced a significance
dose dependent antinociceptive effect against thermal
pain starting at the dose 7.5 mg/kg (Table 2). One way
ANOVA test showed that the addition of aspirin (100 mg/
kg) significantly potentiated the antinociceptive effect
of imipramine (PB0.01). This was shown (comparing
between the group that was given imipramine only with
the group that was given imipramine plus aspirin) to take
place with the lowest (2.5 mg/kg) and highest (30 mg/kg)
doses of imipramine (Table 2).
The antinociceptive effect of fluoxetine alone
and in combination with aspirin
Fluoxetine produced significant dose dependent antino-
ciceptive effect against thermal pain (Table 3). The
addition of aspirin (100 mg/kg) significantly potentiated
the antinociceptive effect of different doses of fluoxetine
(PB0.01, one-way ANOVA). This was shown to take
place with 2.5 mg/kg of fluoxetine (Table 3).
Table 1. The antinociceptive effect of different doses of
aspirin against thermal induced pain
Treatments The percentage increase in reaction time
Normal saline 101.493.1
Aspirin (50 mg kg) 102.192.6
Aspirin (100 mg/kg) 106.595.4
Aspirin (200 mg/kg) 108.898.6
Values are mean9SE of six animals.
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and in combination with aspirin
Mirtazapine produced dose dependent antinociceptive
effect against thermal induced pain (Table 4). The
addition of aspirin (100 mg/kg) significantly potentiated
the antinociceptive effect of different doses of mirtaza-
pine (PB0.001, one-way ANOVA). This potentiation
was statistically significant with all the doses of mirtaza-
pine (Table 4).
Discussion
To the best of our knowledge the analgesic interactions
between aspirin and antidepressants that increase the
availability of serotonin and/or noradrenaline have not
been evaluated previously. Hot plate nociception is
commonly used to test for acute CNS analgesia; this
test is selective in detecting analgesic action of morphine
like drugs. All antidepressants used in this study pro-
duced a dose-depended anti-nociception in the hotplate
test which was significantly potentiated by a middle dose
of aspirin. Aspirin by itself lacks any analgesic effect in
this test. These antidepressants are known to increase the
synaptic availability of monoamines by different mechan-
isms, where imipramine inhibits the uptake mechanism
for both 5-HT and NA, fluoxetine blocks selectively the
uptake of 5-HT, while mirtazapine is believed to increase
both noradrenergic and serotonergic neurotransmission
via blockade of central alpha2 adrenergic auto- and
heteroreceptors increasing the availability of both amines
at the synapse (9). Noradrenergic and serotonergic
descending inhibitory and excitatory pathways are be-
lieved to play an important role in endogenous analgesic
Table 2. The antinociceptive effect of different doses of imipramine alone and in combination with 100 mg/kg aspirin against
thermal induced pain
Treatment Imipramine dose (mg/kg) Percentage increase in reaction time Percentage change from control group
Normal saline  101.493.1 0
Aspirin (100mg/kg)  106.595.4 5.1
Imipramine 2.5 108.897.8 7.3
Imipramineaspirin 2.5 131.297.9*# 29.4
Imipramine 7.5 126.295.8* 24.5
Imipramineaspirin 7.5 142.8911.5* 40.8
Imipramine 15 136.397.68* 34.4
Imipramineaspirin 15 152.5914* 50.4
Imipramine 30 175.297.5* 72.8
Imipramineaspirin 30 195.794.38*# 93
Values are mean9SE of six animals.
*Significantly differs from control normal saline group.
#Significantly differs from the corresponding group that received imipramine only.
Table 3. The antinociceptive effect of different doses of ﬂuoxetine alone and in combination with 100 mg/kg aspirin against
thermal induced pain
Treatment Fluoxetine dose (mg/kg) Percentage increase in reaction time Percentage change from control
Normal saline  101.493.1 
Aspirin (100 mg/kg)  106.595.4 5.1
Fluoxetine 1.25 112.692.7* 11.1
FluoxetineAspirin 1.25 113.296.21* 11.6
Fluoxetine 2.5 116.293.3* 14.7
FluoxetineAspirin 2.5 129.3193.06*# 27.5
Fluoxetine 5 117.5794.12* 15.9
FluoxetineAspirin 5 121.9195.6* 20.2
Fluoxetine 7.5 124.6796.4* 22.9
FluoxetineAspirin 7.5 126.895.6* 25.0
Values are mean9SE of six animals.
*Significantly different from control normal saline values.
#Significantly different from the corresponding group that received fluoxetine only.
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(page number not for citation purpose)systems (10). Both noradrenaline and serotonin produce
membrane hyperpolarization, while decreasing the
excitatory transmitter release from primary Ad and C
afferent fibers presynaptically and increasing the
inhibitory transmitter release, including both GABA
and glycine, from the interneurons (11).
Fluoxetine produced less analgesia when compared
with imipramine and mirtazapine (an increases in reac-
tion time for fluoxetine from 11 to 22%, 7.3 to 72.8% for
imipramine and 3440% for mirtazapine). If we believe
that both noradrenergic and serotonergic descending
pathways play an important role in endogenous analgesic
systems (12), then it is logic to suggest that fluoxetine
being a selective serotonin uptake inhibitor would
produce less analgesic effect than imipramine and
mirtazapine both of which are known to increase the
levels of both amines at the synapse.
Aspirin have been the traditional treatment for mod-
erate pain and inflammation. Aspirin and its derivatives
diminish postoperative hyperalgesia peripherally, primar-
ily through inhibition of cyclooxygenase (COX) enzymes
in the spinal cord and periphery (13). The combination of
aspirin with the selected antidepressants resulted in a
potentiation of analgesia in the following order (mirta-
zapine [2253%], imipramine [1622%] then fluoxetine
[0.512.8%]. The addition of aspirin resulted in a
significant potentiation for all doses of mirtazapine.
The same results were obtained with imipramine except
that the potentiation was significant only with the
smallest (2.5 mg/kg) and the highest (30 mg/kg) doses
of imipramine. The insignificant effect of the middle
doses of imipramine might be related to the relatively
higher standard error seen with these groups. The results
obtained with fluoxetine are more difficult to explain,
since the addition of aspirin resulted in very small
potentiation to the analgesic effect which was significant
with only the 2.5 mg/kg dose.
The potentiation of aspirin to the analgesic effect of
these antidepressants doesn’t seem to be additive, as the
magnitude of the final effect of the combination was
more than the sum of each response separately. Aspirin,
by inhibiting peripheral and central cyclooxygenase and
decreasing prostaglandin synthesis (14), likely reduced
the activation and sensitization of peripheral primary
afferents as well as central spinothalamic tract neurons,
while the selected antidepressants likely enhanced des-
cending inhibition of spinothalamic tract neurons (15).
When combined, the two pharmacologic mechanisms
appear to produce greater-than-additive effects. More-
over, previous studies have shown that analgesia induced
by central infusion of NSAIDs was antagonized in
monkeys by pretreatment with either the serotonergic
receptor antagonist cyproheptadine or the alpha-2 adre-
nergic receptor antagonist yohimbine (16). In addition,
activation of descending serotonergic inhibitory circuits
has been proposed as a mechanism to account, at least in
part, for the analgesic action of several NSAIDs (1718).
Thus, in addition to the possible pharmacologic interac-
tions between cyclooxygenase inhibition produced by
aspirin and the increased availability of the monoamines
produced by the antidepressants, aspirin may have
enhanced monoaminergic neurotransmission to an addi-
tional degree which resulted in the potentiation of the
analgesic effect of these antidepressants.
It can be concluded therefore that the differing
mechanisms of action of these drugs allows for improved
analgesia when they are used in combination, even at
reduced doses. Combination analgesic therapy can in-
crease the efficacy of pain management and reduce side
effects, minimizing pain and reducing recovery time.
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Table 4. The antinociceptive effect of different doses of mirtazapine alone and in combination with 100 mg/kg aspirin against
thermal induced pain
Treatment Mirtazapine dose (mg/kg) Percentage increase in reaction time Percentage change from control
Normal saline  101.493.1 
Aspirin (100 mg/kg)  106.595.4 5.1
Mirtazapine 1.25 135.999.85* 34.0
MirtazapineAspirin 1.25 158.395.1*# 56.1
Mirtazapine 2.5 135.895.76* 33.9
MirtazapineAspirin 2.5 189.8911.2*# 87.1
Mirtazapine 5 142.395.37* 40.3
MirtazapineAspirin 5 180.6917.3*# 78.1
Values are mean9SE of six animals.
*Significantly different from control normal saline values.
#Significantly different from the corresponding group that received mirtazapine only.
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